Skip to content

Medical emergency? What to do

New culprit behind obesity's ill metabolic consequences

3-RXPublished July 7, 20094 min read

Key points

  • Obesity very often leads to insulin resistance, and now researchers reporting in the July 8 issue of Cell Metabolism, a Cell Press publication, have uncovered another factor behind that ill consequence.
  • Elevated PEDF is also associated with increased release of fatty acids from fat stores, which causes blood lipid levels to rise.
  • In recent years, scientists have come to appreciate fat cells as important regulators of metabolism, at least in part through the hormones and other chemicals they secrete.
  • Indeed, they now report that PEDF levels in fat and blood are higher in rodents who are obese for different reasons.

Obesity very often leads to insulin resistance, and now researchers reporting in the July 8 issue of Cell Metabolism, a Cell Press publication, have uncovered another factor behind that ill consequence. The newly discovered culprit—a protein known as pigment epithelium-derived factor (PEDF for short)—is secreted by fat cells. They also report evidence to suggest that specifically blocking that protein's action may reverse some of the health complications that come with obesity.

"With obesity, PEDF release is increased from fat, leading to higher levels of PEDF in the bloodstream," said Matthew Watt of Monash University in Australia. "PEDF sends a signal to other body tissues, causing insulin resistance in muscle and liver, a major defect that leads to the development of type 2 diabetes."

Elevated PEDF is also associated with increased release of fatty acids from fat stores, which causes blood lipid levels to rise. That "dyslipidemia" may be associated with other complications including cardiovascular disease.

What's more, they found that treatments designed to block the action of PEDF in obese mice lowered the animals' blood lipid levels and reversed some of their insulin resistance, Watt said.

In recent years, scientists have come to appreciate fat cells as important regulators of metabolism, at least in part through the hormones and other chemicals they secrete. Changes in fat-cell size are also accompanied by reprogramming of the fat-cell secretory profile, a shift that is thought to play an important role in the link between obesity and insulin resistance, the researchers said. That has led scientists in search of all the chemicals issued by fat tissue—the so-called adipocyte secretome—in hopes of identifying regulatory players with as-yet-unidentified roles in whole-body metabolism.

In the current study, a screen of molecules secreted by fat cells turned up PEDF as one of the most abundant. Watt said they took particular note of the protein because prior evidence from their lab and others had shown that PEDF rises in the bloodstream of patients with type 2 diabetes more than in those who remained insulin sensitive. "We also observed in a separate study that, when mice lost weight by calorie restriction or pharmaceutical intervention, PEDF in fat cells was reduced," he explained.

Indeed, they now report that PEDF levels in fat and blood are higher in rodents who are obese for different reasons. PEDF levels dropped when the animals lost weight. Lean mice injected with PEDF also become less responsive to insulin and show signs of inflammation in both muscle and liver. In the long term, PEDF contributes to elevated fatty acids in the blood, they found.

"These fatty acids are then transported into muscle and liver, where they accumulate," Watt said. "Fat accumulation in muscle and liver is a bad thing as it can cause insulin resistance."

The findings identify PEDF as a "bona fide adipocyte secretory factor," the researchers concluded. The observations made in mice are particularly exciting, they said, given that circulating PEDF was recently found to be high in people with metabolic syndrome—a collection of risk factors including too much belly fat, high cholesterol, high blood pressure, and insulin resistance—and in those with type 2 diabetes.

###

The researchers include Seamus Crowe, Monash University, Victoria, Australia; Lindsay E. Wu, Garvan Institute of Medical Research, New South Wales, Australia, University of New South Wales, Sydney, Australia; Catherine Economou, Monash University, Victoria, Australia; Sarah M. Turpin, Monash University, Victoria, Australia, University of Melbourne, Victoria, Australia; Maria Matzaris, Monash University, Victoria, Australia; Kyle L. Hoehn, Garvan Institute of Medical Research, New South Wales, Australia; Andrea L. Hevener, University of California, Los Angeles, CA; David E. James, Garvan Institute of Medical Research, New South Wales, Australia; Elia J. Duh, Johns Hopkins University School of Medicine, Baltimore, MD; and Matthew J. Watt, Monash University, Victoria, Australia.

Contact: Cathleen Genova
cgenova@cell.com
617-397-2802
Cell Press

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.